Cargando…

Discovery and Preclinical Development of Antigiardiasis Fumagillol Derivatives

Giardiasis, caused by the intestinal parasite Giardia lamblia, is a severe diarrheal disease, endemic in poverty-stricken regions of the world, and also a common infection in developed countries. The available therapeutic options are associated with adverse effects, and G. lamblia resistance to the...

Descripción completa

Detalles Bibliográficos
Autores principales:	Padia, Janak, Kulakova, Liudmila, Galkin, Andrey, Herzberg, Osnat
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Society for Microbiology 2020
Materias:	Experimental Therapeutics
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7508583/ https://www.ncbi.nlm.nih.gov/pubmed/32778548 http://dx.doi.org/10.1128/AAC.00582-20

Ejemplares similares

Crystal Structures of Carbamate Kinase from Giardia lamblia Bound with Citric Acid and AMP-PNP
por: Lim, Kap, et al.
Publicado: (2013)

Remodeling of Fumagillol: Discovery of an Oxygen-Directed Oxidative Mannich Reaction
por: Grenning, Alexander J., et al.
Publicado: (2014)

Remodeling of the Natural Product Fumagillol Employing a Reaction Discovery Approach
por: Balthaser, Bradley R., et al.
Publicado: (2011)

A Homogenous Luminescence Assay Reveals Novel Inhibitors for Giardia Lamblia Carbamate Kinase
por: Chen, Catherine Z, et al.
Publicado: (2012)

Preclinical Pharmacokinetics and Safety of Intravenous RTD-1
por: Park, A. Young J., et al.
Publicado: (2022)

Development and Preclinical Evaluation of New Inhaled Lipoglycopeptides for the Treatment of Persistent Pulmonary Methicillin-Resistant Staphylococcus aureus Infections
por: Plaunt, Adam J., et al.
Publicado: (2021)

Preclinical evaluation of the antiproliferative potential of STI571 in Hodgkin's disease
por: Re, D, et al.
Publicado: (2002)

Photodynamic diagnosis of ovarian cancer using hexaminolaevulinate: a preclinical study
por: Lüdicke, F, et al.
Publicado: (2003)

Preclinical Evaluation of the Stability, Safety, and Efficacy of CD101, a Novel Echinocandin
por: Ong, Voon, et al.
Publicado: (2016)

Parasite Viability as a Measure of In Vivo Drug Activity in Preclinical and Early Clinical Antimalarial Drug Assessment
por: Radohery, Georges F. R., et al.
Publicado: (2022)

Preclinical studies of targeted α therapy for breast cancer using (213)Bi-labelled-plasminogen activator inhibitor type 2
por: Allen, B J, et al.
Publicado: (2003)

Interleukin-13-Overexpressing Mice Represent an Advanced Preclinical Model for Detecting the Distribution of Antimycobacterial Drugs within Centrally Necrotizing Granulomas
por: Walter, Kerstin, et al.
Publicado: (2022)

In Silico-Based High-Throughput Screen for Discovery of Novel Combinations for Tuberculosis Treatment
por: Singh, Ragini, et al.
Publicado: (2015)

Preclinical Antimalarial Combination Study of M5717, a Plasmodium falciparum Elongation Factor 2 Inhibitor, and Pyronaridine, a Hemozoin Formation Inhibitor
por: Rottmann, Matthias, et al.
Publicado: (2020)

Preclinical Data on the Gardnerella-Specific Endolysin PM-477 Indicate Its Potential to Improve the Treatment of Bacterial Vaginosis through Enhanced Biofilm Removal and Avoidance of Resistance
por: Landlinger, Christine, et al.
Publicado: (2022)

Discovery of Novel Oral Protein Synthesis Inhibitors of Mycobacterium tuberculosis That Target Leucyl-tRNA Synthetase
por: Palencia, Andrés, et al.
Publicado: (2016)

Computational Chemogenomics Drug Repositioning Strategy Enables the Discovery of Epirubicin as a New Repurposed Hit for Plasmodium falciparum and P. vivax
por: Ferreira, Letícia Tiburcio, et al.
Publicado: (2020)

Structure-Activity Relationships of a Series of Echinocandins and the Discovery of CD101, a Highly Stable and Soluble Echinocandin with Distinctive Pharmacokinetic Properties
por: James, Kenneth D., et al.
Publicado: (2017)

Integrated preclinical and clinical development of mTOR inhibitors in pancreatic cancer
por: Garrido-Laguna, I, et al.
Publicado: (2010)

A novel combretastatin A-4 derivative, AC7700, strongly stanches tumour blood flow and inhibits growth of tumours developing in various tissues and organs
por: Hori, K, et al.
Publicado: (2002)

Activity of Chitosan and Its Derivatives against Leishmania major and Leishmania mexicana In Vitro
por: Riezk, Alaa, et al.
Publicado: (2020)

Porphyrin synthesis from ALA derivatives for photodynamic therapy. In vitro and in vivo studies
por: Perotti, C, et al.
Publicado: (2004)

Antileishmanial Effects of Synthetic EhPIb Analogs Derived from the Entamoeba histolytica Lipopeptidephosphoglycan
por: Fehling, Helena, et al.
Publicado: (2020)

Role of platelet-derived endothelial cell growth factor/thymidine phosphorylase in fluoropyrimidine sensitivity
por: de Bruin, M, et al.
Publicado: (2003)

Effect of a tumour-derived lipid-mobilising factor on glucose and lipid metabolism in vivo
por: Russell, S T, et al.
Publicado: (2002)

Inhibition of platelet-derived growth factor signalling induces autophagy in malignant glioma cells
por: Takeuchi, H, et al.
Publicado: (2004)

Implication of mitochondria-derived ROS and cardiolipin peroxidation in N-(4-hydroxyphenyl)retinamide-induced apoptosis
por: Asumendi, A, et al.
Publicado: (2002)

Single- and Multiple-Ascending-Dose Study of the Safety, Tolerability, and Pharmacokinetics of the Polymyxin Derivative SPR206
por: Bruss, Jon, et al.
Publicado: (2021)

Thrombin-Derived C-Terminal Peptide Reduces Candida-Induced Inflammation and Infection In Vitro and In Vivo
por: Dahlman, Anna, et al.
Publicado: (2021)

Expression of uncoupling proteins-1, -2 and -3 mRNA is induced by an adenocarcinoma-derived lipid-mobilizing factor
por: Bing, C, et al.
Publicado: (2002)

Preferential expression of hPGFS in primary SCCHN and tumour cell lines derived from respiratory and digestive organs
por: Li, S, et al.
Publicado: (2004)

Induction of breast cancer resistance protein by the camptothecin derivative DX-8951f is associated with minor reduction of antitumour activity
por: van Hattum, A H, et al.
Publicado: (2002)

Microvascular mechanisms by which the combretastatin A-4 derivative AC7700 (AVE8062) induces tumour blood flow stasis
por: Hori, K, et al.
Publicado: (2003)

Impact of antibody framework residue V(H)-71 on the stability of a humanised anti-MUC1 scFv and derived immunoenzyme
por: Krauss, J, et al.
Publicado: (2004)

Inhibition of epidermoid carcinoma A431 cell growth and angiogenesis in nude mice by early and late treatment with a novel dextran derivative
por: Di Benedetto, M, et al.
Publicado: (2003)

Thiram inhibits angiogenesis and slows the development of experimental tumours in mice
por: Marikovsky, M
Publicado: (2002)

Abrogation of the radiation-induced G2 checkpoint by the staurosporine derivative UCN-01 is associated with radiosensitisation in a subset of colorectal tumour cell lines
por: Playle, L C, et al.
Publicado: (2002)

Inhibition of IL-6+IL-6 soluble receptor-stimulated aromatase activity by the IL-6 antagonist, Sant 7, in breast tissue-derived fibroblasts
por: Purohit, A, et al.
Publicado: (2003)

Growth-inhibitory and cell cycle-arresting properties of the rice bran constituent tricin in human-derived breast cancer cells in vitro and in nude mice in vivo
por: Cai, H, et al.
Publicado: (2004)

Induction of tumour blood flow stasis and necrosis: a new function for epinephrine similar to that of combretastatin A-4 derivative AVE8062 (AC7700)
por: Hori, K, et al.
Publicado: (2004)

Cannot write session to /tmp/vufind_sessions/sess_ejg81pfhafcld58fl8ceibuufg